Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1074220.RAKy_eWuEKXKAz_j4Bx728DGw24GjCYT5KrY4GdBdXpkk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1074220.RAKy_eWuEKXKAz_j4Bx728DGw24GjCYT5KrY4GdBdXpkk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1074220.RAKy_eWuEKXKAz_j4Bx728DGw24GjCYT5KrY4GdBdXpkk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1074220.RAKy_eWuEKXKAz_j4Bx728DGw24GjCYT5KrY4GdBdXpkk130_provenance.
- NP1074220.RAKy_eWuEKXKAz_j4Bx728DGw24GjCYT5KrY4GdBdXpkk130_assertion description "[Restoring of MSH3 expression by cDNA transfection, rather than by chromosome transfer, did not affect colon cancer sensitivity to oxaliplatin or PARPi monotherapy; PARP-1 levels seemed to be more crucial for the outcome of PARPi monotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1074220.RAKy_eWuEKXKAz_j4Bx728DGw24GjCYT5KrY4GdBdXpkk130_provenance.
- NP1074220.RAKy_eWuEKXKAz_j4Bx728DGw24GjCYT5KrY4GdBdXpkk130_assertion evidence source_evidence_literature NP1074220.RAKy_eWuEKXKAz_j4Bx728DGw24GjCYT5KrY4GdBdXpkk130_provenance.
- NP1074220.RAKy_eWuEKXKAz_j4Bx728DGw24GjCYT5KrY4GdBdXpkk130_assertion SIO_000772 23636450 NP1074220.RAKy_eWuEKXKAz_j4Bx728DGw24GjCYT5KrY4GdBdXpkk130_provenance.
- NP1074220.RAKy_eWuEKXKAz_j4Bx728DGw24GjCYT5KrY4GdBdXpkk130_assertion wasDerivedFrom befree-2016 NP1074220.RAKy_eWuEKXKAz_j4Bx728DGw24GjCYT5KrY4GdBdXpkk130_provenance.
- NP1074220.RAKy_eWuEKXKAz_j4Bx728DGw24GjCYT5KrY4GdBdXpkk130_assertion wasGeneratedBy ECO_0000203 NP1074220.RAKy_eWuEKXKAz_j4Bx728DGw24GjCYT5KrY4GdBdXpkk130_provenance.
- befree-2016 importedOn "2016-02-19" NP1074220.RAKy_eWuEKXKAz_j4Bx728DGw24GjCYT5KrY4GdBdXpkk130_provenance.